Welcome to the Second Global Oncothon, organized by OncoDaily in collaboration with SIOP! This 24-hour global event, held on International Childhood Cancer Day, brings together world-renowned experts to discuss the challenges, advancements, and solutions in pediatric oncology.
Moderator:
???? Shushan Hovsepyan – Pediatric Oncologist & Editor-in-Chief, OncoDaily Medical Journal
Featured Speakers:
???? Professor Ching-Tien Peng – China Medical University’s Children’s Hospital, Taiwan
???? Dr. Akihiro Yoneda – National Center for Child Health and Development, Japan
Key topics include:
✅ The latest innovations in pediatric cancer treatment
✅ The role of precision medicine in improving survival rates
✅ Challenges in low- and middle-income countries and global collaboration efforts
✅ The impact of fundraising and advocacy in transforming childhood cancer care
Join the movement! Donate & spread awareness to make a difference in the lives of children battling cancer. ????????
#Cancer #GlobalOncothon #OncoDaily #SIOP #ChildhoodCancer #PediatricOncology #CancerAdvocacy #InternationalChildhoodCancerDay #CancerAwareness #OncologyExperts #PrecisionMedicine #CancerResearch #GlobalHealth #CancerTreatment #FundraisingForCancer #MedicalAdvancements
SUBSCRIBE to get the latest #oncodaily https://www.youtube.com/@OncoDailyTV
Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn: https://linkedin.com/company/oncodaily
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram: https://www.instagram.com/oncodailynews/
Follow OncoDaily on TikTok: https://www.tiktok.com/@oncodaily
Like OncoDaily on Facebook: https://www.facebook.com/oncodaily/
SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter
About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”
Moderator:
???? Shushan Hovsepyan – Pediatric Oncologist & Editor-in-Chief, OncoDaily Medical Journal
Featured Speakers:
???? Professor Ching-Tien Peng – China Medical University’s Children’s Hospital, Taiwan
???? Dr. Akihiro Yoneda – National Center for Child Health and Development, Japan
Key topics include:
✅ The latest innovations in pediatric cancer treatment
✅ The role of precision medicine in improving survival rates
✅ Challenges in low- and middle-income countries and global collaboration efforts
✅ The impact of fundraising and advocacy in transforming childhood cancer care
Join the movement! Donate & spread awareness to make a difference in the lives of children battling cancer. ????????
#Cancer #GlobalOncothon #OncoDaily #SIOP #ChildhoodCancer #PediatricOncology #CancerAdvocacy #InternationalChildhoodCancerDay #CancerAwareness #OncologyExperts #PrecisionMedicine #CancerResearch #GlobalHealth #CancerTreatment #FundraisingForCancer #MedicalAdvancements
SUBSCRIBE to get the latest #oncodaily https://www.youtube.com/@OncoDailyTV
Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn: https://linkedin.com/company/oncodaily
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram: https://www.instagram.com/oncodailynews/
Follow OncoDaily on TikTok: https://www.tiktok.com/@oncodaily
Like OncoDaily on Facebook: https://www.facebook.com/oncodaily/
SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter
About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”
- Category
- Oncology

Be the first to comment